K Gersak1, T Tomazevic. 1. Department of Obstetrics and Gynecology, University Medical Center, Ljubljana, Slovenia.
Abstract
PURPOSE: Our purpose was to find the differences in granulosa-luteal cells obtained from gonadotropin-versus gonadotropin-releasing hormone (GnRH) agonist/gonadotropin-treated follicles in in vitro fertilization-embryo transfer (IVF-ET) cycles. METHODS: Granulosa-luteal cells were obtained from 45 follicles of women undergoing IVF-ET with gonadotropin releasing hormone (GnRH) agonist and human menopausal gonadotropin (hMG) and from 45 follicles of women with hMG IVF-ET cycles. Subpopulations of granulosa-luteal cells were observed by computerized image analysis in which human chorionic gonadotropin (hCG) was localized using immunoperoxidase staining. RESULTS: The luteinized granulosa-luteal cells from hMG-treated follicles were larger than those from GnRH agonist/hMG-treated follicles. The hMG-treated follicles contained more hCG-stained cells, particularly those with cytoplasmic hCG localization. CONCLUSIONS: We found differences in morphometric characteristics and hCG localization in granulosa-luteal cells obtained from hMG-versus GnRH agonist/hMG-treated follicles. We presume that the results indicate the influence and importance of luteal-phase support on the clinical pregnancy rate in GnRH agonist/hMG-treated IVF-ET cycles.
PURPOSE: Our purpose was to find the differences in granulosa-luteal cells obtained from gonadotropin-versus gonadotropin-releasing hormone (GnRH) agonist/gonadotropin-treated follicles in in vitro fertilization-embryo transfer (IVF-ET) cycles. METHODS: Granulosa-luteal cells were obtained from 45 follicles of women undergoing IVF-ET with gonadotropin releasing hormone (GnRH) agonist and human menopausal gonadotropin (hMG) and from 45 follicles of women with hMG IVF-ET cycles. Subpopulations of granulosa-luteal cells were observed by computerized image analysis in which humanchorionic gonadotropin (hCG) was localized using immunoperoxidase staining. RESULTS: The luteinized granulosa-luteal cells from hMG-treated follicles were larger than those from GnRH agonist/hMG-treated follicles. The hMG-treated follicles contained more hCG-stained cells, particularly those with cytoplasmic hCG localization. CONCLUSIONS: We found differences in morphometric characteristics and hCG localization in granulosa-luteal cells obtained from hMG-versus GnRH agonist/hMG-treated follicles. We presume that the results indicate the influence and importance of luteal-phase support on the clinical pregnancy rate in GnRH agonist/hMG-treated IVF-ET cycles.
Authors: J Latouche; M Crumeyrolle-Arias; D Jordan; N Kopp; B Augendre-Ferrante; L Cedard; F Haour Journal: Endocrinology Date: 1989-09 Impact factor: 4.736
Authors: R L Stouffer; G D Hodgen; P E Graves; D R Danforth; K M Eyster; J S Ottobre Journal: J Clin Endocrinol Metab Date: 1986-05 Impact factor: 5.958
Authors: A C Van Steirteghem; J Smitz; M Camus; L Van Waesberghe; J Deschacht; I Khan; C Staessen; A Wisanto; C Bourgain; P Devroey Journal: Hum Reprod Date: 1988-02 Impact factor: 6.918
Authors: J Smitz; P Devroey; M Camus; J Deschacht; I Khan; C Staessen; L Van Waesberghe; A Wisanto; A C Van Steirteghem Journal: Hum Reprod Date: 1988-07 Impact factor: 6.918
Authors: K A Hutchinson-Williams; B Lunenfeld; M P Diamond; G Lavy; S P Boyers; A H DeCherney Journal: Fertil Steril Date: 1989-09 Impact factor: 7.329
Authors: K A Hutchinson-Williams; A H DeCherney; G Lavy; M P Diamond; F Naftolin; B Lunenfeld Journal: Fertil Steril Date: 1990-03 Impact factor: 7.329